Chemoinformaics analysis of 3,4-Dihydroxy-2-Piperidinomethanol
| Molecular Weight | 304.184 | nRot | 2 |
| Heavy Atom Molecular Weight | 286.04 | nRig | 12 |
| Exact Molecular Weight | 303.047 | nRing | 2 |
| Solubility: LogS | -2.281 | nHRing | 1 |
| Solubility: LogP | -0.342 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 38.5983 |
| nHD | 4 | BPOL | 20.0077 |
| QED | 0.57 |
| Synth | 3.162 |
| Natural Product Likeliness | 1.336 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.118 |
| CACO-2 | -4.961 |
| MDCK | 0.00000583 |
| BBB | 0.021 |
| PPB | 0.210589 |
| VDSS | 2.103 |
| FU | 0.766442 |
| CYP1A2-inh | 0.04 |
| CYP1A2-sub | 0.643 |
| CYP2c19-inh | 0.038 |
| CYP2c19-sub | 0.259 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.227 |
| CYP2d6-inh | 0.146 |
| CYP2d6-sub | 0.756 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.237 |
| CL | 16.111 |
| T12 | 0.824 |
| hERG | 0.051 |
| Ames | 0.453 |
| ROA | 0.679 |
| SkinSen | 0.936 |
| Carcinogencity | 0.066 |
| EI | 0.02 |
| Respiratory | 0.6 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.60139 |